Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors

By afschroeder • October 29, 2026

Ganz PA, Van Dyk K, Crespi CM, Petersen L, Sedrak MS, Bower JE. Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors. JCO Oncol Adv. 2026 Jan;3(4):e2600063. doi: 10.1200/oa-26-00063. Epub 2026 Oct 20. PMID: 42948761; PMCID: PMC13712313.

Tags: Hematology/Oncology, Publications

Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study

McKean M, Chmielowski B, Butler MO, Carvajal RD, Rodon J, Carlino MS, Kim KB, Wise-Draper TM, Khan S, Salama AKS, Moser J, Ang A, Barrios[...]

Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study

Naeim A, Cheng J, Spiegel B, Bakshian A, Tetrault E, Mehra M, Amini D, Krut Z, Shang H, Sedrak MS, Bui A, Johnson T, Wang[...]

Venous Thromboembolism in Pregnancy

Huynh K, Olevsky O, Mok T. Venous Thromboembolism in Pregnancy. Obstet Gynecol Clin North Am. 2026 Dec;53(4):723-746. doi: 10.1016/j.ogc.2026.07.001. Epub 2026 Sep 16. PMID: 42951441.